| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |